Forte Biosciences (FBRX) Share-based Compensation Growth (3y) (2019 - 2026)
Forte Biosciences (FBRX) Share-based Compensation Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 244.08% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -50.27% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -0.04% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 38.45% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Forte Biosciences | 174.08 Mn | 115.88 Mn | - | 53.58% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 53.58% |
| Dec 31, 2025 | 24.61% |
| Sep 30, 2025 | 17.75% |
| Jun 30, 2025 | 7.78% |
| Mar 31, 2025 | 117.25% |
| Dec 31, 2024 | -17.43% |
| Sep 30, 2024 | -18.72% |
| Jun 30, 2024 | -7.34% |
| Mar 31, 2024 | 17.60% |
| Dec 31, 2023 | 26.52% |
| Sep 30, 2023 | 27.21% |
| Jun 30, 2023 | 229.04% |
| Mar 31, 2023 | 659.73% |
| Dec 31, 2022 | 202.72% |
| Sep 30, 2022 | 668.01% |
| Jun 30, 2022 | 960.88% |
| Mar 31, 2022 | -57.09% |
| Dec 31, 2021 | -10.90% |
| Sep 30, 2021 | -8.57% |
| Jun 30, 2021 | -15.52% |